albertbourla
Albert Bourla, chief executive officer of Pfizer, estimates $54 billion in sales from its Covid-19 vaccine and new treatment pill Paxlovid in 2022. The COVID-19 shots are expected to generate $32 billion and Paxlovid is estimated to bring in $22 billion. Paxlovid, a new antiviral coronavirus treatment pill, received authorization from the FDA in December. This pill has already contributed $76 million in U.S sales. Pfizer expects to produce six million courses of Paxlovid for the first quarter and 120 million by the end of the year. According to Pfizer, Paxlovid reduces the risk of hospitalizat...
uPolitics.com
Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Monday, January 10. Following is a link to video on CNBC.com: Q4 2021 hedge fund letters, conferences and more Pfizer CEO Bourla: Omicron-Specific Covid Vaccine Will Be Ready By MarchANDREW ROSS SORKIN: Welcome back to “Squawk Box.” All day today, CNBC brings you the biggest names from the virtual J.P. Morgan Healthcare Conference. Meg Tirrell joins us with another very special guest this morning. Meg. MEG TIRRELL: Andrew, thanks ...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Monday, November 29. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Pfizer Could Have A New Vaccine Against Omicron Covid Variant In Less Than 100 Days, CEO Albert Bourla SaysMEG TIRRELL: Well Andrew, thanks so much. Albert Borla, the CEO of Pfizer joins us now. Albert, it’s really great to have you on with us this morning and I want to start by asking you about PAXLOVID, your Covid anti...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Friday, November 5. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Pfizer To Submit Covid Pill To FDA Before Thanksgiving, Says CEO Albert BourlaAll references must be sourced to CNBC. ANDREW ROSS SORKIN: Welcome back to “Squawk Box.” We’re going to get straight over to Meg Tirrell who has a special guest this morning with some big news. Meg. MEG TIRRELL: Absolutely Andrew, joining us no...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “The Exchange” (M-F, 1PM-2PM ET) today, Tuesday, November 2. Following is a link to video on CNBC.com: Q3 2021 hedge fund letters, conferences and more Pfizer CEO Is 'Optimistic' On Covid Vaccine For Kids Under Age FiveMEG TIRRELL: Hey Kelly. Well, a big beat for Pfizer in the quarter, a lot of that of course driven by their COVID-19 vaccine that beating both for the third quarter expectations and for the forecast for the full year, which Pfizer now raised to deliveri...
ValueWalk
Following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) Chairman and CEO Albert Bourla on CNBC’s “Squawk Box” (M-F, 6AM-9AM ET) today, Wednesday, September 22. Following is a link to video on CNBC.com: Q2 2021 hedge fund letters, conferences and more Pfizer CEO On Providing 500 Million Vaccines To Low Income CountriesMEG TIRRELL: That special guest is Albert Bourla, the CEO of Pfizer. Albert, thanks for being with us this morning. Let's start with the news of the day, at least 500 million doses add to a previous agreement for the same number. They started shippin...
ValueWalk
Pfizer and BioNTech will seek emergency authorization from Food and Drug Administration (FDA) for their COVID-19 vaccine to be administered for children under 5 in November, Pfizer’s Chief Financial Officer Frank D’Amelio said at an industry conference on Tuesday. Pfizer has also previously revealed that the company is preparing to file for emergency use authorization for children ages 5 to 11 by October. Pfizer’s CEO Albert Bourla also said that the company plans to release clinical trial data on its COVID-19 vaccine’s efficacy for children under five as early as the end of October. “Then, it...
uPolitics.com
Following is the unofficial transcript of a CNBC exclusive interview with Pfizer Chairman and CEO Albert Bourla on CNBC’s “The Exchange” (M-F, 1PM-2PM ET) today, Wednesday, July 28. Following are links to video on CNBC.com: Q2 2021 hedge fund letters, conferences and more Pfizer Sees 10 Percent Operational Growth With Covid VaccineCovid Immunity Wanes 6 Months After The Pfizer VaccineAll references must be sourced to CNBC. MEG TIRRELL: Hey Kelly. Well, let’s start with the second quarter. Pfizer posting a beat and a raise for the quarter, a lot of that of course driven by its massive COVID-19 ...
ValueWalk
The following is the unofficial transcript of a CNBC interview with Pfizer Inc. (NYSE:PFE) CEO Albert Bourla from the CNBC Evolve Global Summit, which took place today, Wednesday, June 16th. Video from the interview will be available at cnbc.com/evolve. Q1 2021 hedge fund letters, conferences and more Interview With Pfizer CEO Albert BourlaANDREW ROSS SORKIN: Tyler, thank you, and Albert, thank you. Thank you for being here. And let me say on behalf of the world, thank you for the work that Pfizer and your team have done to get us to where we are today, and hopefully where we're going tomorrow...
ValueWalk
On Wednesday, the International Olympic Committee (IOC) announced the signing of a deal with pharmaceutical giant Pfizer to supply vaccines for athletes participating in the Olympics. The IOC and Pfizer reached a memorandum of understanding to supply the Olympics with enough vaccines to cover the athletes. This would enable the upcoming summer Tokyo Olympics to be safer despite pressure to cancel it because the Japanese government handled the coronavirus. “This donation of the vaccine is another tool in our toolbox of measures to help make the Olympic and Paralympic Games Tokyo 2020 safe and s...
uSports.org
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら